What Lymphoma Patients Need to Know About Current Treatments for COVID-19
As of mid-2022, there are a number of treatments for COVID-19 that have been either approved by the FDA or have been authorized for emergency use (EUA).
Lymphoma Research Foundation Names Sarah Quinlan Chief Program Officer The Lymphoma Research Foundation (LRF) –…
The U.S. Food and Drug Administration Approves Lisocabtagene Maraleucel (Breyanzi) for Large B-Cell Lymphoma On…